CHEMBIO DIAGNOSTICS, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 8 rows in 2020. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-12-17: Reporting owner Acheson David; Form 4; Security Nonqualified stock options; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-03-16: Reporting owner Goldman Neil A; Form 4; Security Option to purchase; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-03-16: Reporting owner POLAN MARY LAKE PH D; Form 4; Security Option to purchase; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-03-16: Reporting owner Passas Robert; Form 4; Security Option to purchase; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-12-17 | Acheson David Director | 4 | Nonqualified stock options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,781 23,781 owned after | $5.45 exercise price | 2020-12-18 | |
| 2020-03-16 | Goldman Neil A Officer (See Remarks) | 4 | Option to purchase Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +159,725 159,725 owned after | $2.36 exercise price | 2020-03-18 | |
| 2020-03-16 | POLAN MARY LAKE PH D Director | 4 | Option to purchase Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,252 36,252 owned after | $2.36 exercise price | 2020-03-18 | |
| 2020-03-16 | Passas Robert Officer (See Remarks) | 4 | Option to purchase Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +107,170 107,170 owned after | $2.36 exercise price | 2020-03-18 | |
| 2020-03-16 | Esfandiari Javan Officer (See Remarks) | 4 | Option to purchase Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +188,064 188,064 owned after | $2.36 exercise price | 2020-03-18 | |
| 2020-03-16 | PAGE GAIL S Director | 4 | Option to purchase Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,252 36,252 owned after | $2.36 exercise price | 2020-03-18 | |
| 2020-03-16 | Davis Katherine Lyon Director | 4 | Option to purchase Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,252 36,252 owned after | $2.36 exercise price | 2020-03-18 | |
| 2020-03-16 | Potthoff John Gary Director | 4 | Option to purchase Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,252 36,252 owned after | $2.36 exercise price | 2020-03-18 |